Compare RICK & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RICK | PRQR |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.9M | 250.7M |
| IPO Year | 1995 | 2014 |
| Metric | RICK | PRQR |
|---|---|---|
| Price | $27.28 | $2.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $98.00 | $8.14 |
| AVG Volume (30 Days) | 128.0K | ★ 558.5K |
| Earning Date | 12-12-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 252.84 | N/A |
| EPS | ★ 1.86 | N/A |
| Revenue | ★ $281,738,000.00 | $18,859,556.00 |
| Revenue This Year | $3.62 | N/A |
| Revenue Next Year | $8.86 | N/A |
| P/E Ratio | $14.51 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.88 | $1.07 |
| 52 Week High | $61.66 | $3.46 |
| Indicator | RICK | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 57.24 | 53.75 |
| Support Level | $25.00 | $2.15 |
| Resistance Level | $29.45 | $2.42 |
| Average True Range (ATR) | 1.34 | 0.19 |
| MACD | 0.49 | 0.04 |
| Stochastic Oscillator | 62.45 | 79.70 |
RCI Hospitality Holdings Inc through its subsidiaries owns and operates establishments that offer live adult entertainment, restaurant, and or bar operations. It also owns and operates a communication company serving the adult nightclub industry. The company's operating business segments are Nightclubs, Bombshells, and Others. It operates nightclubs through the following brands Rick's Cabaret, Vivid Cabaret, Tootsie's Cabaret, Club Onyx, and Jaguars Club. In the Bombshells segment, the company is building a chain of Restaurants and Sports Bars in Dallas, Austin, and Houston, Texas. It derives the majority of revenue from the Nightclubs segment that engages in the sale of alcoholic beverages, food, and merchandise items; service in the form of cover charges, dance fees, and room rentals.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.